Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

HGS achieves milestone in and expands agreement with Roche

July 18, 1997

Novel antibacterial oxazolidinones from Pharmacia & Upjohn

July 18, 1997

Isis and Ciba Vision sign distribution agreement for novel CMV retinitis drug

July 17, 1997

SIGA and Wyeth-Ayerst commence discovery program for novel antiinfectives

July 17, 1997

Preliminary results from IMpact-RSV trial

July 17, 1997

Sequus and Sam Yang sign marketing agreement for Amphocil

July 16, 1997

Katayama's new cephems

July 16, 1997

Toyama claims antibacterial agents

July 16, 1997

New carbapenem ester prodrug claimed by Nippon Lederle

July 16, 1997

FDA approves antibacterial generic from Mylan

July 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...